Medical technology company BD on Wednesday that it will invest $100 million in its plant in Holdrege to expand capacity for its insulin syringe manufacturing operations.

"BD is committed to helping improve the injection experience for the millions of people who live with diabetes, as demonstrated by our long history of innovative firsts—the first insulin syringe ...